Objective-We conducted a whole-genome, multipoint linkage screen to localize a previously reported major locus accounting for 56% to 67% of the additive genetic effects on covariate-adjusted plasma HDL cholesterol (HDL-C) levels in Mexican Americans from the San Antonio Family Heart Study (SAFHS). Methods and Results-After using complex segregation analysis to recover the major locus in 472 SAFHS participants from 10 genotyped families, we incorporated covariates required to detect that major locus, including plasma levels of triglycerides and apolipoprotein A-I, in a maximum-likelihood-based variance-components linkage screen. Only chromosome 16 exhibited convincing evidence for a quantitative trait locus (QTL), with a peak multipoint log of the odds (LOD)ϭ3.73 (Pϭ0.000034). Subsequent penetrance model-based linkage analysis, incorporating genotypes at the marker locus nearest the multipoint peak (D16S518) into the segregation model, detected linkage with the previously detected major locus (LODϭ2.73, Pϭ0.000642). Initial estimates place this QTL within a 15-cM region of chromosome 16q near the structural loci for lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP). Key Words: HDL Ⅲ genome screen Ⅲ linkage Ⅲ heritability Ⅲ Mexican Americans W e previously reported a major locus influencing quantitative variation in plasma HDL cholesterol (HDL-C) levels in Mexican-American families from the San Antonio Family Heart Study (SAFHS). 1 This major-locus effect, accounting for 56% to 67% of the additive genetic variance in HDL-C in those families, was detected only when the effects of age and sex terms plus plasma levels of apolipoprotein A-I (apo A-I) and triglycerides (TG), exogenous sex hormone use, and menopause status were included in the complex segregation analysis model for the trait. In males and females, respectively, the major locus accounted for 11% and 4% of the total phenotypic variance in plasma total HDL-C levels and for 55% and 21% of the residual phenotypic variance, ie, the proportion of the phenotypic variance not attributable to the effects of covariates. Because genotype data were not available for a whole-genome linkage screen when this major locus first was detected, we attempted to identify a locus responsible for this effect by means of combined segregation and linkage analysis with genotype data for likely candidate loci. Results of these analyses 1 were both definitive and negative, excluding linkage between the major locus for residual HDL-C and structural loci for several proteins of lipoprotein metabolism, namely, APOA-I, APOB, LDLR, LIPC, and LPL, on chromosomes 11q, 2p, 19p, 15q, and 8p, respectively.
Conclusions-A QTL influencing plasma levels of HDL-C inAlthough subsequent analyses of data from the SAFHS and other studies have mapped quantitative trait loci (QTLs) for HDL-C-related measures to chromosome 1q 2 , chromosome 13q, 3,4 and chromosome 9p 5 , other reports localize HDL-Crelated QTLs to some chromosomal regions containing candidate loci ...